Technical Analysis for KYTX - Kyverna Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Very Strong | N/A | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
NR7 | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
MACD Bullish Signal Line Cross | Bullish | 5.95% | |
Doji - Bearish? | Reversal | 5.95% | |
Wide Bands | Range Expansion | 5.95% | |
Gapped Up | Strength | 5.95% | |
180 Bearish Setup | Bearish Swing Setup | 10.71% | |
NR7 | Range Contraction | 10.71% | |
Wide Bands | Range Expansion | 10.71% | |
Oversold Stochastic | Weakness | 10.71% |
Alert | Time |
---|---|
Possible NR7 | about 8 hours ago |
Rose Above Previous Day's High | about 12 hours ago |
Up 5% | about 12 hours ago |
Up 3% | about 12 hours ago |
Up 2% | about 12 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
Kyverna is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. Our lead product candidate, KYV-101 is advancing through clinical development across two broad areas of autoimmune disease: rheumatology and neurology, including Phase 2 trials for multiple sclerosis and myasthenia gravis, a Phase 1/2 trial for systemic sclerosis, and two ongoing multi-center, open-label Phase 1 trials in the United States and Germany for patients with lupus nephritis.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Autoimmune Disease Autoimmunity Multiple Sclerosis Lupus Rheumatology Myasthenia Gravis Lupus Nephritis Sjögren Syndrome Systemic Sclerosis
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Autoimmune Disease Autoimmunity Multiple Sclerosis Lupus Rheumatology Myasthenia Gravis Lupus Nephritis Sjögren Syndrome Systemic Sclerosis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 35.06 |
52 Week Low | 12.26 |
Average Volume | 395,903 |
200-Day Moving Average | 0.00 |
50-Day Moving Average | 21.77 |
20-Day Moving Average | 16.07 |
10-Day Moving Average | 14.59 |
Average True Range | 1.50 |
RSI (14) | 41.52 |
ADX | 50.84 |
+DI | 13.15 |
-DI | 28.46 |
Chandelier Exit (Long, 3 ATRs) | 18.80 |
Chandelier Exit (Short, 3 ATRs) | 16.76 |
Upper Bollinger Bands | 20.35 |
Lower Bollinger Band | 11.80 |
Percent B (%b) | 0.43 |
BandWidth | 53.25 |
MACD Line | -2.18 |
MACD Signal Line | -2.43 |
MACD Histogram | 0.2534 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 16.97 | ||||
Resistance 3 (R3) | 16.88 | 16.31 | 16.73 | ||
Resistance 2 (R2) | 16.31 | 15.93 | 16.35 | 16.64 | |
Resistance 1 (R1) | 15.90 | 15.70 | 16.11 | 15.99 | 16.56 |
Pivot Point | 15.33 | 15.33 | 15.43 | 15.37 | 15.33 |
Support 1 (S1) | 14.92 | 14.95 | 15.13 | 15.01 | 14.44 |
Support 2 (S2) | 14.35 | 14.72 | 14.39 | 14.36 | |
Support 3 (S3) | 13.94 | 14.35 | 14.28 | ||
Support 4 (S4) | 14.03 |